{
  "nct_id": "NCT06105918",
  "official_title": "Phase 1 Trial to Determine Safety and Feasibility in Treating Biochemical Recurrence Post-Prostatectomy with PSMA PET Guided External Beam Radiotherapy Followed by Consolidative Radioligand Therapy",
  "brief_title": "Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients with Biochemically Recurrent Prostate Cancer",
  "cancer_type_display": "A study for post-prostatectomy patients with biochemically recurrent prostate adenocarcinoma with cancer detected only in the pelvis.",
  "cancer_tags": [
    "Biochemically Recurrent Prostate Carcinoma",
    "Prostate Adenocarcinoma"
  ],
  "link_to_trial": "https://clinicaltrials.gov/study/NCT06105918",
  "phase": "Phase 1",
  "recruitment_status": "RECRUITING",
  "last_update_date": "2024-12-27",
  "enrollment": 10,
  "min_age": 18,
  "max_age": null,
  "sex": "MALE",
  "is_metastatic_allowed": false,
  "performance_status_scale": "ECOG",
  "performance_status_values": [
    0,
    1,
    2
  ],
  "min_prior_lines": null,
  "max_prior_lines": null,
  "prior_treatments_required": [
    "Radical prostatectomy"
  ],
  "prior_treatments_excluded": [
    "Prior pelvic radiotherapy",
    "Prior RLT (Radioligand therapy)"
  ],
  "principal_investigator": "David M Schuster, MD, FACR",
  "site_name": "Emory University Hospital/Winship Cancer Institute",
  "contact_email": "dschust@emory.edu",
  "contact_phone": "404-712-4859",
  "locations": [
    {
      "facility": "Emory University Hospital/Winship Cancer Institute",
      "status": "RECRUITING",
      "city": "Atlanta",
      "state": "Georgia",
      "zip": "30322",
      "country": "United States",
      "contacts": [
        {
          "name": "David M. Schuster, MD, FACR",
          "role": "CONTACT",
          "phone": "404-712-4859",
          "email": "dschust@emory.edu"
        },
        {
          "name": "Bridget Fielder, RN",
          "role": "CONTACT",
          "email": "bfielde@emory.edu"
        },
        {
          "name": "David M. Schuster, MD, FACR",
          "role": "CONTACT"
        }
      ],
      "geoPoint": {
        "lat": 33.749,
        "lon": -84.38798
      }
    }
  ],
  "key_inclusion_summary": [
    "Adenocarcinoma of the prostate, post radical prostatectomy with detectable prostate specific antigen (PSA).",
    "Clinical PSMA PET/CT obtained, with findings of pelvic uptake only (prostate bed, pelvic lymph node uptake, or both).",
    "Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status of 0-2.",
    "Age over 18."
  ],
  "key_exclusion_summary": [
    "Contraindications to radiotherapy (including active inflammatory bowel disease or prior pelvic radiotherapy or prior RLT).",
    "Definitive findings of systemic metastasis on prior imaging or biopsy.",
    "Renal insufficiency (GFR < 60 mL/min).",
    "Baseline >= grade 2 myelosuppression (e.g., platelet count less than 75 x 10^9 /L).",
    "Severe acute co-morbidity, such as unstable angina or recent myocardial infarction."
  ]
}